Durability of Three Monthly Loading Doses with Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration.

Ophthalmol Ther · 2026 · PMC13249987 · PMID 42105126

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendp = 0.079so close (0.05 < p ≤ 0.1)

Increasing age showed a trend toward a lower hazard of reinjection (HR per year 0.99, 95% CI 0.98 to 1.00; p = 0.079).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.